2014
Integrated Diabetes Oncology Care, Janelle M. Sharma DNP, CRNP; Gregory R. Harper MD, PhD; Cara Habeck RN, CDE; Cathy A. Coyne PhD, MPH; Roya Hamadani MPH; Hope Kincaid MPH, CPH; Ada M. Rivera BA; Gretchen A. Perilli MD; and Nicole R. Sully DO (Presentation)
Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer., Mohamedtaki A Tejani, Anna ter Veer, Dana Milne, Rebecca Ottesen, Tanios Bekaii-Saab, Al B Benson, Deborah Schrag, Stephen Shibata, John Skibber, Martin Weiser, Neal Wilkinson, and Steven J Cohen (Article)
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines., Margaret A Tempero, Mokenge P Malafa, Stephen W Behrman, Al B Benson, Ephraim S Casper, E Gabriela Chiorean, Vincent Chung, Steven J Cohen, Brian Czito, Anitra Engebretson, Mary Feng, William G Hawkins, Joseph Herman, John P Hoffman, Andrew Ko, Srinadh Komanduri, Albert Koong, Andrew M Lowy, Wen Wee Ma, Nipun B Merchant, Sean J Mulvihill, Peter Muscarella, Eric K Nakakura, Jorge Obando, Martha B Pitman, Sushanth Reddy, Aaron R Sasson, Sarah P Thayer, Colin D Weekes, Robert A Wolff, Brian M Wolpin, Jennifer L Burns, and Deborah A Freedman-Cass (Article)
Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer., Alan A Thomay, David M Nagorney, Steven J Cohen, Elin R Sigurdson, Mark J Truty, Barbara Burtness, Michael J Hall, and Yun Shin Chun (Article)
Factors affecting specimen accrual in a community hospital biobank., Sameer Tolay MD and C S. Shelley (Article)
Stem cell transplantation as a dynamical system: are clinical outcomes deterministic?, Amir Toor MD, Jared D Kobulnicky, Salman Salman, Catherine H Roberts, Max Jameson-Lee, Jeremy Meier, Allison Scalora, Nihar Sheth, Vishal Koparde, Myrna Serrano, Gregory A Buck, William B Clark, John M McCarty, Harold M Chung, Masoud H Manjili, Roy T Sabo, and Michael C Neale (Article)
Burkitt Lymphoma Presenting as Left Lateral Rectus Palsy, Daniel Tseytlin DO and Usman Shah MD (Poster)
Targeted immunotherapy for non-small cell lung cancer., Monali Vasekar, Xin Liu, Hong Zheng, and Chandra P Belani (Article)
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission., Erica D Warlick; Kristjan Paulson; Ruta Brazauskas; Xiaobo Zhong; Alan M Miller; Bruce M Camitta; Biju George; Bipin N Savani; Celalettin Ustun; David I Marks; Edmund K Waller; Frédéric Baron; César O Freytes; Gérard Socie; Gorgun Akpek; Harry C Schouten; Hillard M Lazarus; Edwin M Horwitz; John Koreth; Jean-Yves Cahn; Martin Bornhauser; Matthew Seftel; Mitchell S Cairo; Mary J Laughlin; Mitchell Sabloff; Olle Ringdén; Robert Peter Gale; Rammurti T Kamble; Ravi Vij; Usama Gergis MD, MBA; Vikram Mathews; Wael Saber; Yi-Bin Chen; Jane L Liesveld; Corey S Cutler; Armin Ghobadi; Geoffrey L Uy; Mary Eapen; Daniel J Weisdorf; and Mark R Litzow (Article)
KRAS Codon 12 and 13 Mutations in Relation to Disease-freeSurvival in BRAF-wild-type Stage III Colon Cancers from an Adjuvant ChemotherapyTrial (N0147 Alliance)., Harry H. Yoon; David Tougeron; Qian Shi; Steven R. Alberts MD, MPH; Michelle R. Mahoney; Garth D. Nelson; Suresh G. Nair MD; Stephen N. Thibodeau; Richard M. Goldberg; Daniel J. Sargent; and Frank A. Sinicrope (Article)
Alterations of LKB1 and KRAS and Risk of Brain Metastasis: Comprehensive Characterization by Mutation Analysis, Copy Number, and Gene Expression in Non-Small-Cell Lung Carcinoma., Ni Zhao, Matthew D. Wilkerson, Usman Shah MD, Xiaoying Yin, Anyou Wang, Michele C. Hayward, Patrick Roberts, Carrie B. Lee, Alden M. Parsons, Leigh B. Thorne, Benjamin E. Haithcock, Juneko E. Grilley-Olson, Thomas E. Stinchcombe, William K. Funkhouser, Kwok-Kin Wong, Norman E. Sharpless, and D Neil Hayes (Article)
2013
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer., C Aggarwal, N J Meropol, C J Punt, N Iannotti, B H Saidman, K D Sabbath, N Y Gabrail, J Picus, M A Morse, E Mitchell, M C Miller, and S J Cohen (Article)
Randomized phase II trial of extended versus standard neoadjuvant therapy for esophageal cancer, NCCTG (Alliance) trial N0849., Steven Alberts, Gamini S. Soori, Qian Shi, Dennis Wigle, Robert Sticca, Robert Clell Miller, James Leenstra, Patrick J. Peller, Tsung-Teh Wu, Harry H. Yoon, Timothy F. Drevyanko, Stephen Ko, Bassam Ibrahim Mattar, Daniel Nikcevich, Robvert J. Behrens, Maged Khalil MD, and George P. Kim (Article)
Efficacy of cabozantinib (Cabo) in medullary thyroid cancer (MTC) patients with RAS or RET mutations: Results from a phase III study, M Brose (Article)
Increase in blood pressure with sorafenib exposure: Renal cell carcinoma (RCC) versus other solid tumors, M Brose (Article)
Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial, M Brose (Article)
Timing and severity of skin-related adverse events in a phase II trial of sorafenib (BAY43-9006) in patients with advanced thyroid cancer, M Brose (Article)
Differences in patterns of care and outcomes of elderly versus younger metastatic pancreatic cancer (mPC) patients, S J. Cohen (Article)
Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer, S J. Cohen (Article)
Safety and efficacy of 90y resin microspheres in elderly (≥70 years) compared to younger patients with colorectal liver metastases (mCRC), S J. Cohen (Article)
Cabozantinib in progressive medullary thyroid cancer., Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl, Bruno Niederle, Ezra E W Cohen, Lori J Wirth, Haythem Ali, Colin Hessel, Yifah Yaron, Douglas Ball, Barry Nelkin, and Steven I Sherman (Article)
Determinants Of Cost Of Care For Persons With Severe Hemophilia, Michael W. Evans MD, MPH (Article)
Myelodysplastic syndromes: toward a risk-adapted treatment approach., Bishoy Faltas; Amer Zeidan; and Usama Gergis MD, MBA (Article)
Online medical professionalism: patient and public relationships: policy statement from the American College of Physicians and the Federation of State Medical Boards., Jeanne M Farnan, Lois Snyder Sulmasy, Brooke K Worster, Humayun J Chaudhry, Janelle A Rhyne, and Vineet M Arora (Article)
Assessment of T-Cell Reconstitution After Two Step Haploidentical Stem Cell Transplants by Measurement of T-Cell Receptor Excision Circles (TREC), Joanne Filicko (Article)
A 2 Step Approach To Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Low Non-Relapse Related Mortality (NRM) and High Overall Survival (OS) Rates Confirmed In Second Generation Trial, Joanne Filicko-O'Hara (Article)
A 2-Step Approach to Myeloablative Haploidentical Stem Cell Transplantation with Optimized T-Cell Dosing: Early Immune Reconstitution Leads to Better Outcomes, Joanne Filicko-O'Hara (Article)
Is comparative effectiveness research emphasized in oncologic residency training programs? Results of a national survey., Joanne Filicko-O'Hara (Article)
The Addition Of Bortezomib (Velcade®) To The Combination Of Mitoxantrone and Etoposide For Relapsed Or Refractory Acute Leukemia Does Not Appear To Improve The Likelihood Of Response: Results Of a Phase II Trial, Joanne Filicko-O'Hara (Article)
Unbalanced translocation t(1;12)(q10;q10): A state of bone marrow insufficiency due to trisomy 1q?, Joanne Filicko-O'Hara (Article)
Improving quality of care within the NCI Community Cancer Centers Program (NCCCP) network., Eliot L. Friedman MD (Article)
Thoracic Multidisciplinary Clinic (TMDC) and the Treatment of Stage III Non-Small Cell Lung Cancer, Eliot L. Friedman MD, Michael F. Szwerc MD, Robert Kruklitis MD, and Michael J. Weiss (Poster)
Predicting therapy response in live tumor cells isolated with the flexible micro spring array device., Jean-Nicolas Gallant, Elizabeth M Matthew, Hairong Cheng, Ramdane Harouaka, Nicholas Lamparella DO, Miriam Kunkel, Zhaohai Yang, Harold A Harvey, Leah V Cream, Suresh M Kumar, Gavin P Robertson, Siyang Zheng, Joseph J Drabick, Cristina I Truica, and Wafik S El-Deiry (Article)
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia., Usama Gergis MD, MBA; Gail Roboz; Tsiporah Shore; Ellen Ritchie; Sebastian Mayer; Usama Wissa; Marshall McKenna; Paul Christos; Roger Pearse; Tomer Mark; Joseph Scandura; Koen van Besien; and Eric Feldman (Article)
Controlling health hazards to hospital workers., Theresa Gorman, Jonathan Dropkin, Jacob Kamen, Somashekhar Nimbalkar, Norman Zuckerman, Thomas Lowe, Jaime Szeinuk, Debra Milek, George Piligian, and Alice Freund (Article)
Investigating the prognostic value of a panel of biomarkers after curative intent resection of pancreatic ductal adenocarcinoma., Benny Johnson, Maged Khalil MD, Joseph Blansfield, Fan Lin, Shaobo Zhu, and Lester Kirchner (Article)
Phase 1b Study Of The MDM2 Antagonist RG7112 In Combination With 2 Doses/Schedules Of Cytarabine, M Kasner (Article)
Plasma MN (carbonic anhydrase IX) and outcome in sunitinib-treated metastatic renal cell cancer., Nicholas Lamparella DO, S M. Ali, K Leitzel, W P. Carney, and A Lipton (Article)
Impact of genetic markers on treatment of non-small cell lung cancer., Nicholas Lamparella DO, Amit Barochia, and Salah Almokadem (Article)
Contradictory KRAS mutation test results in a patient with metastatic colon cancer: a clinical dilemma in the era of personalized medicine., Nicholas Lamparella DO, Bikramajit S Saroya, Zhaohai Yang, Nabeel E Sarwani, and Wafik S El-Deiry (Article)
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204., Jerome C Landry, Yang Feng, Steven J Cohen, Charles A Staley, Richard Whittington, Elin Ruth Sigurdson, Halla Nimeiri, Udit Verma, Roshan S Prabhu, and Al Bowen Benson (Article)
Physician and stakeholder perceptions of conflict of interest policies in oncology., A Craig Lockhart, Marcia S Brose, Edward S Kim, David H Johnson, Jeffrey M Peppercorn, Dina L Michels, Courtney D Storm, Lynn M Schuchter, and W Kimryn Rathmell (Article)
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma., Tomer M Mark; Whitney Reid; Ruben Niesvizky; Usama Gergis MD, MBA; Roger Pearse; Sebastian Mayer; June Greenberg; Morton Coleman; Koen Van Besien; and Tsiporah Shore (Article)
Fractal organization of the human T cell repertoire in health and after stem cell transplantation., Jeremy Meier, Catherine Roberts, Kassi Avent, Allison Hazlett, Jennifer Berrie, Kyle Payne, David Hamm, Cindy Desmarais, Catherine Sanders, Kevin T Hogan, Kellie J Archer, Masoud H Manjili, and Amir Toor MD (Article)
Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications., Ewelina Morawa; Peter Martin; Usama Gergis MD, MBA; Koen van Besien; and Tsiporah Shore (Article)
Melanoma Update, Suresh G. Nair MD (Presentation)
Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2, Michael p. O'Connell; Katie Marchbank; Marie R. Webster; Alexander A. Valiga; Amanpreet Kaur; Adina Vultur; Ling Li; Meenhard Herlyn; Jessie Villanueva; Qin Liu; Xiangfan Yin; Sandy Widura; Janelle Nelson; Nivia Ruiz; Tura C. Camilli; Fred E. Indig; Keith T. Flaherty; Jennifer A. Wargo; Dennie T. Frederick; Zachary A. Cooper; Suresh G. Nair MD; Ravi K. Amaravadi; Lynn M. Schuchter; Giorgos C. Karakousis; Wei Xu; Xiaowei Xu MD, PhD; and Ashani T. Weeraratna (Article)
A feasibility trial using molecular-guided therapy for the treatment of patients with refractory or recurrent neuroblastoma, Nehal S Parikh MD (Article)
Diabetic Ketoacidosis: A Review and Update, Gretchen Perilli MD, Christine Saraceni, Michael N. Daniels DO, and Aakif N. Ahmad DO (Article)
Zidovudine (AZT)-induced aneuploidy, mediated by Stathmin 1 (STMN1), involves a loss of polymerized β-tubulin, Andrea Rivera MD, MS (Article)
Dissecting Pin1 and phospho-pRb regulation., Flavio Rizzolio, Isabella Caligiuri, Chiara Lucchetti, Roberto S Fratamico MD, Valentina Tomei, Gaia Gallo, Alexis Agelan, Giovanni Ferrari, Giuseppe Toffoli, Andres J Klein-Szanto, and Antonio Giordano (Article)
Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology., Bruce J Roth, Lada Krilov, Sylvia Adams, Carol A Aghajanian, Peter Bach, Fadi Braiteh, Marcia S Brose, Lee M Ellis, Harry Erba, Daniel J George, Mark R Gilbert, Joseph O Jacobson, Eric C Larsen, Stuart M Lichtman, Ann H Partridge, Jyoti D Patel, David I Quinn, Leslie L Robison, Jamie H von Roenn, Wolfram Samlowski, Gary K Schwartz, and Nicholas J Vogelzang (Article)
An Outcome-Adaptive Allocation Method for Clinical Trials With Dual Binary Objectives, Roy T. Sabo, Cathy Roberts, Amir Toor MD, and John M. McCarty (Article)
Plasmablastic Lymphoma of the Maxillary Sinus in an HIV-negative Patient: a Case Report and Literature Review, Christine Saraceni, Nicole M. Agostino DO, Dennis B. Cornfield MD, and Ranju Gupta MD (Article)
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial., R C Smallridge, J A Copland, M S Brose, J T Wadsworth, Y Houvras, M E Menefee, K C Bible, M H Shah, A W Gramza, J P Klopper, L A Marlow, M G Heckman, and R Von Roemeling (Article)
Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma., Lauren M Tait, Joshua E Meyer, Erin McSpadden, Jonathan D Cheng, Frank A Baciewicz, Neal J Meropol, Steven J Cohen, Antoinette J Wozniak, Minsig Choi, and Andre A Konski (Article)
Hematopoietic Cell Yield Declines Predictably Over Time During Apheresis, Amir Toor MD (Article)
Emerging molecular therapies for the treatment of acute lymphoblastic leukemia., Monali Vasekar, Joshua E Allen, Jamal Joudeh, and David Claxton (Article)
Palliative Care “Bucket List”—Skills Learned From Difficult Cases, B Worster (Article)
Fatal malignant metastastic epithelioid angiomyolipoma presenting in a young woman: case report and review of the literature., Edward Wyluda, Giselle Baquero, Nicholas Lamparella DO, Catherine Abendroth, and Joseph Drabick (Article)
Early-Phase Clinical Trials in the Community: Results from the National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment., Howard A. Zaren, Suresh G. Nair MD, Ronald S. Go, Rebecca A. Enos, Keith S. Lanier, Michael A. Thompson, Jinxiu Zhao, Deborah L. Fleming, John C. Leighton, Thomas E. Gribbin, Donna M. Bryant, Angela Carrigan, Jennifer C. Corpening, Kimberly A. Csapo, Eileen P. Dimond, Christie Ellison, Maria M. Gonzalez, Jodi L. Harr, Kathy Wilkinson, and Andrea M. Denicoff (Article)
2012
Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial, Steven R. Alberts MD, MPH; Tom R. Fitch MD; George P. Kim MD; Bruce W. Morlan MS; Shaker R. Dakhil MD; Howard M. Gross MD; and Suresh G. Nair MD (Article)
Effect of Oxaliplatin, Fluorouracil, and Leucovorin with or Without Cetuximab on Survival Among Patients with Resected Stage III Colon Cancer: A Randomized Trial., Steven R. Alberts MD, MPH; Daniel J. Sargent; Suresh G. Nair MD; Michelle R. Mahoney; Margaret Mooney; Stephen N. Thibodeau; Thomas C. Smyrk; Frank A. Sinicrope; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; Anthony F. Shields; James T. Quesenberry; Thomas A. Webb; Gist H. Farr; Barbara A. Pockaj; Axel Grothey; and Richard M. Goldberg (Article)
The hedgehog pathway in breast cancer., Sheikh Asim Ali MD (Article)
Survival outcomes in pregnancy associated breast cancer: a retrospective case control study., Sheikh Asim Ali MD, Sameer Gupta, Rajesh Sehgal, and Victor Vogel (Article)
Does the use of complementary and alternative medicine (CAM) influence survival in glioblastoma multiforme?, P Ambady and Tara Morrison MD (Article)
The kinetics of the excision repair cross-complementing group-1 (ERCC1) gene in patients with colorectal cancer., A Basu Mallick (Article)
Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation., Jennifer L Berrie, Maciej Kmieciak, Roy T Sabo, Catherine H Roberts, Michael O Idowu, Katherine Mallory, Harold M Chung, John M McCarty, Christian A Borrelli, Michelle M Detwiler, A Latif Kazim, Amir Toor MD, and Masoud H Manjili (Article)
Antitumor activity of cabozantinib (XL184) in a cohort of patients (pts) with differentiated thyroid cancer (DTC), M Brose (Article)
In search of a real "targeted" therapy for thyroid cancer., Marcia S Brose (Article)
Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma., Marcia S Brose, Johannes Smit, Jaume Capdevila, Rossella Elisei, Christopher Nutting, Fabian Pitoia, Bruce Robinson, Martin Schlumberger, Young Kee Shong, and Hiroshi Takami (Article)
Clinical Activity and Pharmacokinetics (PK) of Cabozantinib (XL184) in Patients with Progressive Medullary Thyroid Carcinoma (MTC), M S. Brose (Article)
Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling"., Barbara Burtness, Shanthi Marur, Julie E Bauman, Erica A Golemis, Ranee Mehra, and Steven J Cohen (Article)
Current status of allogeneic HST for chronic myelomonocytic leukemia., H Cheng; V G Kirtani; and Usama Gergis MD, MBA (Article)
Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study., Emily Y Chu, Karolyn A Wanat, Christopher J Miller, Ravi K Amaravadi, Leslie A Fecher, Marcia S Brose, Suzanne McGettigan, Lydia R Giles, Lynn M Schuchter, John T Seykora, and Misha Rosenbach (Article)
A phase IB study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: An Academic GI Cancer Consortium (AGICC) study, S J. Cohen (Article)
Phase I/II, two-part, open-label, multiple-dose, dose-escalation study of siltuximab in patients with solid tumors, S J. Cohen (Article)
U.S. patients receiving resin 90Y microspheres for unresectable colorectal liver metastases: A multicenter study of 506 patients, S J. Cohen (Article)
Philadelphia Chromosome-Negative Myeloproliferative Neoplasm with a Novel Platelet-Derived Growth Factor Receptor-β Rearrangement Responsive to Imatinib, Dennis B. Cornfield MD, Usman Shah MD, Nicholas Cross, Courtney E. Bennett DO, and Guoxian Sun (Article)
RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells., Xiaoyun Dong, Waixing Tang, Stephen Stopenski, Marcia S Brose, Christopher Korch, and Judy L Meinkoth (Article)
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study., Efrat Dotan, Neal J Meropol, Barbara Burtness, Crystal S Denlinger, James Lee, David Mintzer, Fang Zhu, Karen Ruth, Holly Tuttle, Judi Sylvester, and Steven J Cohen (Article)
Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer., E Dotan, N J Meropol, F Zhu, F Zambito, B Bove, K Q Cai, A K Godwin, E A Golemis, I Astsaturov, and S J Cohen (Article)
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity., Rebecca L Elstrom; Peter Martin; Sandra Hurtado Rua; Tsiporah B Shore; Richard R Furman; Jia Ruan; Roger N Pearse; Morton Coleman; Tomer Mark; John P Leonard; and Usama Gergis MD, MBA (Article)
Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia., Michael W. Evans MD, MPH; Anthony D Sung; Ivana Gojo; Michael Tidwell; Jacqueline Greer; Mark Levis; Judith Karp; and Maria R Baer (Article)
Management of refractory acute myeloid leukemia: re-induction therapy or straight to transplantation?, E J Feldman and Usama Gergis MD, MBA (Article)
Bortezomib for Steroid Refractory Acute Graft Versus Host Disease (GVHD), Joanne Filicko-O'Hara (Article)
Comparing prognosis estimates of patients with cancer and their oncologists., Joanne Filicko-O'Hara (Article)
Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway, Joanne Filicko-O'Hara (Article)
Evolution of multidisciplinary care: Experience of the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP)., Eliot L. Friedman MD (Article)
Utility of FDG PET-CT Scan in Determining Pathological Response to Neo-adjuvant Chemo-radiation Therapy in Non-small Cell Lung Cancer (NSCLC), Eliot L. Friedman MD, Michael F. Szwerc MD, Robert Kruklitis MD, Michael J. Weiss MPH, Robert Rienzo MD, and Wen Young MD (Poster)
Successful treatment with tacrolimus of a patient with severe idiopathic thrombocytopenic purpura after allogeneic bone marrow transplantation., Usama Gergis MD, MBA; Mohammed Ibrahim; Mohamed Al-Kazaz; Sonam Parkash; Enas Gergis; and Maria Desancho (Article)
Early-phase (EP) clinical trials (CTs) in the community: Results from the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) Early-Phase Working Group (EPWG) Baseline Assessment Study (BAS)., Ronald S. Go, Howard Zaren, and Suresh G. Nair MD (Presentation)
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel., Bertrand Janne d'Othée, Constantinos T Sofocleous, Nader Hanna, Robert J Lewandowski, Michael C Soulen, Jean-Nicolas Vauthey, Steven J Cohen, Alan P Venook, Matthew S Johnson, Andrew S Kennedy, Ravi Murthy, Jean-Francois Geschwind, and Stephen T Kee (Article)
Treatment of adult ALL: more questions than answers., Margaret T Kasner and Mark Weiss (Article)
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma., Tracy Klayton, Tianyu Li, Jian Q Yu, Lanea Keller, Jonathan Cheng, Steven J Cohen, Neal J Meropol, Walter Scott, Meng Xu-Welliver, and Andre Konski (Article)
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer., Andre Konski, Tianyu Li, Michael Christensen, Jonathan D Cheng, Jian Q Yu, Kevin Crawford, Oleh Haluszka, Jeffrey Tokar, Walter Scott, Neal J Meropol, Steven J Cohen, Alan Maurer, and Gary M Freedman (Article)
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary (CUP) using circulating tumor cells, Nicholas Lamparella DO (Article)